PARTOW KEBRIAEI to Pyridazines
This is a "connection" page, showing publications PARTOW KEBRIAEI has written about Pyridazines.
Connection Strength
0.331
-
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. Am J Hematol. 2024 07; 99(7):1423-1426.
Score: 0.183
-
An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Am J Hematol. 2021 07 01; 96(7):E229-E232.
Score: 0.148